T-cell immunity remains effective against SARS-CoV-2 Omicron subvariants

France Nouvelles Nouvelles

T-cell immunity remains effective against SARS-CoV-2 Omicron subvariants
France Dernières Nouvelles,France Actualités
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 71%

T-cell immunity remains effective against SARS-CoV-2 Omicron subvariants Cell Coronavirus Disease COVID Immunity Omicron TCell biorxivpreprint BioNTech_Group goetheuni TelAvivUni DZIF_ HITRONMainz

By Nidhi Saha, BDSDec 21 2022Reviewed by Benedette Cuffari, M.Sc. In a recent study posted to the bioRxiv* preprint server, researchers report that sublineages of the severe acute respiratory syndrome coronavirus 2 Omicron variant effectively escape B-cell immune responses by modifying neutralizing antibody epitopes.

The SARS-CoV-2 Omicron variant has evolved into multiple sublineages, the earliest of which included BA.1, BA.2, BA.4, and BA.5. More recently, additional Omicron sublineages including BA.4.6, BF.7, BA.2.75, BA.2.75.2, BQ.1.1, and XBB have been identified and are currently emerging as dominant circulating strains to replace the previously dominant BA.5.

Furthermore, triple-vaccinated individuals who experienced breakthrough infections with Omicron sublineages were included in the study. Fourteen of these individuals were infected with BA.1, 19 were infected with BA.2, and 17 were infected with BA.4/BA.5. A history of breakthrough infection with BA.2 in vaccinated individuals led to greater cross-neutralization against BA.4/BA.5 and BA.4.6/BF.7 compared to triple-vaccinated individuals. This neutralization was even more significant after breakthrough infection with BA.4/BA.5, even when quadruple-vaccine recipients were considered.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

NewsMedical /  🏆 19. in UK

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

What is the impact of cholesterol on SARS-CoV-2 Spike protein-mediated membrane fusion?What is the impact of cholesterol on SARS-CoV-2 Spike protein-mediated membrane fusion?Researchers assessed the impact of ceramide (CER) and cholesterol (CHOL) on membrane fusion mediated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
Lire la suite »

SARS-CoV-2 structural proteins trigger periodontal fibrosisSARS-CoV-2 structural proteins trigger periodontal fibrosisResearchers examined the pathological impacts of the structural components of SARS-CoV-2 on human periodontal cells and tissue to understand the association between coronavirus disease 2019 (COVID-19) and deteriorating oral health.
Lire la suite »

The potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in EnglandThe potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in EnglandThe potential effects of receiving 2 SARS-CoV-2 vaccine doses on household transmission in England CDCgov ucl SARSCoV2 vaccine vaccination transmission covid coronavirus covid
Lire la suite »

Study finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccinationStudy finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccinationStudy finds increased risk of POTS after SARS-CoV-2 infection or COVID vaccination Coronavirus Disease COVID SARSCoV2 tachycardia NatureCVR karolinskainst UBuffalo
Lire la suite »

Exploring environmental viral emissions after SARS-CoV-2 Human challengeExploring environmental viral emissions after SARS-CoV-2 Human challengeA recent study captured the dynamics of pre-symptomatic SARS-CoV-2 emissions and reported the extent, magnitude, and routes of viral transmission are heterogeneous, with nasal mucosa being an important source of viral transmission.
Lire la suite »

Review on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infectionsReview on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infectionsReview on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infections MonashUni Nanoparticles Thrombosis COVID19 SARSCoV2
Lire la suite »



Render Time: 2025-03-06 18:49:33